If it is determined that cancer is present, the next step is to decide whether it should be treated or not. This involves using different tools to gather as much supplementary information as possible:

Gleason score: The pathologist analyzing the prostate tissue sample under a microscope assigns a score to the cancer’s character based on what the cancer cells look like and how they are arranged. If the Gleason score is 6, 7 or 8, the probability is high that you and your doctor will receive valuable supplementary information with help from Prostatype to be able to answer the question of whether or to treat or not.
Staging: The urologist tries to determine whether the cancer is left inside the prostate gland, has spread to the adjacent tissues or has spread further into the body. The cancer is classified according to T, N and M categories.
Other factors: The choice of treatment takes into account, for example, the patient’s age, health status, and personal opinions.
Prostatype: An innovative and modern gene-based test that gives doctors and patients additional information about the cancer’s severity before the choice of treatment is made. Read more about Prostatype.